Company Filing History:
Years Active: 1976-1978
Title: Jerry Arnold Weisbach: Innovator in Antibacterial Agents
Introduction
Jerry Arnold Weisbach is a notable inventor based in Cherry Hill, NJ (US). He has made significant contributions to the field of antibacterial agents, holding a total of 9 patents. His work focuses on developing compounds that enhance the effectiveness of antibacterial treatments.
Latest Patents
Weisbach's latest patents include innovative compounds such as Cephamycins as antibacterial agents. One of his notable inventions is the preparation of 7.beta.-Substituted mercaptoacetamido-7.alpha.-methoxycephalosporanic acid and its derivatives. These compounds are recognized for their improved antibacterial properties. Additionally, he has developed protected .alpha.-amino-.alpha.-ureido(thioureido)phenylacetic acids. These cephalosporins feature a .alpha.-amino-(ureidophenyl)acetamido substituent at position 7, achieved through acylation of a 7-aminocephalosporin with a derivative of .alpha.-amino-p(or m)-ureidophenylacetic acid. These compounds also serve as effective antibacterial agents.
Career Highlights
Throughout his career, Weisbach has been associated with SmithKline Corporation, where he has contributed to various research initiatives. His work has been instrumental in advancing the field of antibacterial agents, showcasing his dedication to innovation and improvement in medical treatments.
Collaborations
Weisbach has collaborated with several esteemed colleagues, including John R Hoover and Robert M DeMarinis. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Jerry Arnold Weisbach's contributions to the field of antibacterial agents through his patents and collaborations highlight his role as a significant innovator. His work continues to impact the medical community positively, paving the way for more effective treatments.